Related Experiment Video
Updated: Jun 13, 2025

Author Spotlight: Unveiling the Potential of Unpurified Recombinant AAVs in Cell Culture Research
Published on: October 20, 2023
Factors affecting rAAV titers during triple-plasmid transient transfection in HEK-293 cells
Martina Pistek1, Peter Andorfer1, Reingard Grabherr2
1Gene Therapy Process Development, Baxalta Innovations GmbH, a part of Takeda companies, Uferstraße 15, 2304, Orth an der Donau, Austria.
Abstract:
The efficiency of triple-plasmid transfection in recombinant Adeno-Associated Virus (rAAV) production was analyzed by examining two distinct HEK-293 cells lines. These were categorized as high producer (HP) and low producer (LP) based on their differing levels of productivity under identical conditions. Analysis of RNA expression levels of viral genes revealed disparities in plasmid derived gene expression between the cell lines. Further assessment of transfection efficiency utilizing labeled plasmids revealed lower plasmid uptake and less efficient nuclear transport in LP cell line. Additionally, we observed inferior translation activity in LP, contributing to its shortcomings in overall productivity. In our attempt to optimize plasmid ratios to enhance fully packaged rAAV particle yield, we discovered cell-line-specific optimization potential. The findings highlight the transfection's complexity, urging tailored strategies for improved rAAV production based on each cell line's characteristics, enhancing understanding and guiding further efficiency optimization in rAAV production.

